News

Jun. 8—(Family Features) Obesity is a lifelong health problem that affects more than 42% of American adults and impacts some ethnic and racial groups more than others. According to the U.S. Centers ...
The global obesity Atlas estimates that more than 4 billion people worldwide, 51% of the global population, ... BMI is not everything, and the scale number is not definitive, ...
Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being.
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Sarcopenic obesity, a hidden condition affecting people over 40, causes muscle loss and fat gain without major weight changes ...
Since anti-obesity drugs like GLP-1 receptor agonists, including Ozempic and Wegovy, received regulatory approval, they have evolved from specialised treatments for type 2 diabetes into widely ...
The National Center for Health Statistics measured adults and children to see weight, height and other size trends ...
Beyond the Scale” focuses on obesity as a chronic disease — urging empathy, early intervention, and evidence-based ...
Turkey has launched a nationwide campaign to measure citizens’ weight in public to combat its rising obesity rates — a move critics argue amounts to public fat shaming and government overreach.
That change would mean the end of the large-scale compounding era for obesity drugs. Some telehealth companies have transitioned to agreements with Novo Nordisk and Lilly to sell their medicines ...
That change would mean the end of the large-scale compounding era for obesity drugs. Some telehealth companies have transitioned to agreements with Novo Nordisk and Lilly to sell their medicines ...